Volume 87, Issue 1, Pages 162-168 (January 2015) Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality George R. Bailie, Maria Larkina, David A. Goodkin, Yun Li, Ronald L. Pisoni, Brian Bieber, Nancy Mason, Lin Tong, Francesco Locatelli, Mark R. Marshall, Masaaki Inaba, Bruce M. Robinson Kidney International Volume 87, Issue 1, Pages 162-168 (January 2015) DOI: 10.1038/ki.2014.275 Copyright © 2015 International Society of Nephrology Terms and Conditions
Figure 1 Associations of intravenous (IV) iron dose categories with (a) all-cause mortality and (b) cause-specific mortality. IV iron dose is the total 4-month dose, expressed as average mg/month. Model details are provided in text. Adjustments and effect estimates (95% confidence interval (CI)) are as per Model 6 in Table 2. CV, cardiovascular. Kidney International 2015 87, 162-168DOI: (10.1038/ki.2014.275) Copyright © 2015 International Society of Nephrology Terms and Conditions